Abstract

Chondroitin 4-sulfotransferase, which transfers sulfate from 3'-phosphoadenosine 5'-phosphosulfate to position 4 of N-acetylgalactosamine in chondroitin, was purified 1900-fold to apparent homogeneity with 6.1% yield from the serum-free culture medium of rat chondrosarcoma cells by affinity chromatography on heparin-Sepharose CL-6B, Matrex gel red A-agarose, 3',5'-ADP-agarose, and the second heparin-Sepharose CL-6B. SDS-polyacrylamide gel electrophoresis of the purified enzyme showed two protein bands. Molecular masses of these protein were 60 and 64 kDa under reducing conditions and 50 and 54 kDa under nonreducing conditions. Both the protein bands coeluted with chondroitin 4-sulfotransferase activity from Toyopearl HW-55 around the position of 50 kDa, indicating that the active form of chondroitin 4-sulfotransferase is a monomer. Dithiothreitol activated the purified chondroitin 4-sulfotransferase. The purified enzyme transferred sulfate to chondroitin and desulfated dermatan sulfate. Chondroitin sulfate A and chondroitin sulfate C were poor acceptors. Chondroitin sulfate E from squid cartilage, dermatan sulfate, heparan sulfate, and completely desulfated N-resulfated heparin hardly served as acceptors of the sulfotransferase. The transfer of sulfate to the desulfated dermatan sulfate occurred preferentially at position 4 of the N-acetylgalactosamine residues flanked with glucuronic acid residues on both reducing and nonreducing sides.

Highlights

  • Chondroitin sulfate proteoglycan is found in various tissues and thought to play important roles in various cellular interactions involving cell adhesion (1, 2), regulation of neurite outgrowth (3– 6), migration of neural crest cells (7), binding of phospholipase A2 (8), and an adherence receptor for Plasmodium falciparum-infected erythrocytes (9)

  • The following commercial materials were used: H235SO4 was from DuPont NEN; chondroitinase ACII, chondroitinase ABC, chondroitin sulfate A, chondroitin sulfate C, dermatan sulfate, heparan sulfate, completely desulfated N-resulfated heparin (CDSNS-heparin), ⌬Di-0S, ⌬Di-6S, ⌬Di-4S, ⌬Di-diSD, ⌬Di-diSB, and ⌬Di-diSE were from Seikagaku Corp. (Tokyo, Japan); Partisil SAX-10 was from Whatman; Dulbecco’s modified Eagle’s medium and fetal bovine serum were from Life Technologies, Inc. (Life Tech Oriental, Tokyo, Japan); Cosmedium-001 was from Cosmo-Bio (Tokyo, Japan); Hanks’ solution was from Nissui Pharmaceutical Co

  • Unlike chondroitin 6-sulfotransferase (C6ST) from the culture medium of chick chondrocytes (20), secretion of chondroitin 4-sulfotransferase (C4ST) was not stimulated by the addition of ascorbate to the serum-free medium

Read more

Summary

EXPERIMENTAL PROCEDURES

The following commercial materials were used: H235SO4 was from DuPont NEN; chondroitinase ACII, chondroitinase ABC, chondroitin sulfate A (whale cartilage), chondroitin sulfate C (shark cartilage), dermatan sulfate (pig skin), heparan sulfate (bovine kidney), completely desulfated N-resulfated heparin (CDSNS-heparin), ⌬Di-0S, ⌬Di-6S, ⌬Di-4S, ⌬Di-diSD, ⌬Di-diSB, and ⌬Di-diSE were from Seikagaku Corp. (Tokyo, Japan); Partisil SAX-10 was from Whatman; Dulbecco’s modified Eagle’s medium and fetal bovine serum were from Life Technologies, Inc. (Life Tech Oriental, Tokyo, Japan); Cosmedium-001 (a commercial serum-free culture medium developed for the culture of hybridoma, which contains human transferrin and bovine insulin as growth factors) was from Cosmo-Bio (Tokyo, Japan); Hanks’ solution was from Nissui Pharmaceutical Co. The following commercial materials were used: H235SO4 was from DuPont NEN; chondroitinase ACII, chondroitinase ABC, chondroitin sulfate A (whale cartilage), chondroitin sulfate C (shark cartilage), dermatan sulfate (pig skin), heparan sulfate (bovine kidney), completely desulfated N-resulfated heparin (CDSNS-heparin), ⌬Di-0S, ⌬Di-6S, ⌬Di-4S, ⌬Di-diSD, ⌬Di-diSB, and ⌬Di-diSE were from Seikagaku Corp. (Tokyo, Japan); Partisil SAX-10 was from Whatman; Dulbecco’s modified Eagle’s medium and fetal bovine serum were from Life Technologies, Inc. (Life Tech Oriental, Tokyo, Japan); Cosmedium-001 (a commercial serum-free culture medium developed for the culture of hybridoma, which contains human transferrin and bovine insulin as growth factors) was from Cosmo-Bio (Tokyo, Japan); Hanks’ solution was from Nissui Pharmaceutical Co. Ltd. (Tokyo, Japan); trypsin (from bovine pancreas, type III), penicillin G, streptomycin sulfate, 3Ј,5Ј-ADP, unlabeled PAPS, 3Ј,5Ј-ADP-agarose, and molecular weight standards for SDS-PAGE and gel chromatography were from Sigma-Aldrich Ja- Ltd. (Tokyo, Japan); trypsin (from bovine pancreas, type III), penicillin G, streptomycin sulfate, 3Ј,5Ј-ADP, unlabeled PAPS, 3Ј,5Ј-ADP-agarose, and molecular weight standards for SDS-PAGE and gel chromatography were from Sigma-Aldrich Ja-

The abbreviations used are
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call